Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 25/06/13 | 25/06/16 | 107 sh | $7.70 | $823.9 | +0.3% |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 25/06/12 | 25/06/13 | 103 sh | $8.70 | $896.1 | +0.3% |
Ted D. KellnerDirector | AIM ImmunoTechAIM | Open-market buy | 25/04/11 | 25/04/23 | 1,968,504 sh | $0.03 | $59,055.12 | +196850.4% |
William M. MitchellDirector | AIM ImmunoTechAIM | Open-market buy | 25/04/11 | 25/04/23 | 196,851 sh | $0.03 | $5,905.53 | +60.6% |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 25/04/11 | 25/04/23 | 1,968,504 sh | $0.03 | $59,055.12 | +103.7% |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 25/04/04 | 25/04/07 | 41,000 sh | $0.06 | $2,460 | +2.2% |
Peter W. Rodino IIICOO, Secretary, Gen. Counsel | AIM ImmunoTechAIM | Open-market buy | 25/04/04 | 25/04/04 | 500 sh | $0.09 | $45 | +0.1% |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 25/03/05 | 25/03/06 | 50,000 sh | $0.13 | $6,500 | +2.8% |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 25/03/04 | 25/03/05 | 44,000 sh | $0.12 | $5,280 | +2.5% |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 25/03/04 | 25/03/04 | 83,334 sh | $0.12 | $10,000.08 | +5.0% |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 24/11/21 | 25/01/21 | 20,000 sh | $0.21 | $4,200 | +1.2% |
William M. MitchellDirector | AIM ImmunoTechAIM | Open-market sale | 24/12/19 | 24/12/20 | 4,580 sh | $0.19 | $870.2 | −3.7% |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 24/12/18 | 24/12/19 | 22,727 sh | $0.21 | $4,772.67 | +1.4% |
AIM ImmunoTechAIM | Open-market buy | 24/12/02 | 24/12/04 | 11,112 sh2 trades | $0.21avg. | $2,333.52 | +3.2% | |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 24/11/20 | 24/11/21 | 85,000 sh | $0.20 | $17,000 | +5.5% |
Stewart AppelrouthDirector | AIM ImmunoTechAIM | Open-market buy | 24/11/20 | 24/11/21 | 81,953 sh | $0.19 | $15,571.07 | +34.2% |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 24/11/20 | 24/11/20 | 60,110 sh | $0.18 | $10,819.8 | +4.0% |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 24/09/16 | 24/09/17 | 5,000 sh | $0.30 | $1,500 | +0.3% |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 24/09/13 | 24/09/16 | 20,000 sh | $0.31 | $6,200 | +1.4% |
Thomas K. EquelsCEO & President | AIM ImmunoTechAIM | Open-market buy | 24/05/06 | 24/05/07 | 61,729 sh | $0.41 | $25,308.89 | +8.6% |